You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 22, 2026

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
Mark J Osborn1, Akshay Bhardwaj1, Samuel P Bingea1
1Department of Pediatrics, Division of Blood and Marrow Transplant & Cellular Therapy, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
CRISPR/Cas9 technology enables rapid, single-base specific detection of SARS-CoV-2 using a lateral flow assay. A multiplex assay also differentiates between common respiratory viruses, offering scalable point-of-care diagnostics.
10:16Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
07:46On-site DNA Detection of Trypanosomatid Parasites and Nosema ceranae Through Alkaline Lysis Coupled to RPA/CRISPR/Cas12a System
Published on: July 18, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: